Skip to main content

Optivar Side Effects

Generic name: azelastine ophthalmic

Medically reviewed by Drugs.com. Last updated on Apr 23, 2023.

Note: This document contains side effect information about azelastine ophthalmic. Some dosage forms listed on this page may not apply to the brand name Optivar.

Applies to azelastine ophthalmic: ophthalmic solution.

Serious side effects of Optivar

Along with its needed effects, azelastine ophthalmic (the active ingredient contained in Optivar) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking azelastine ophthalmic:

Less common

Other side effects of Optivar

Some side effects of azelastine ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to azelastine ophthalmic: ophthalmic solution.

Ocular

Very common (10% or more): Burning/stinging (up to 30%)

Common (1% to 10%): Irritation, conjunctivitis, pain

Uncommon (0.1% to 1%): Temporary blurring[Ref]

General

The most common side effect reported was eye irritation such as burning/stinging.[Ref]

Respiratory

Common (1% to 10%): Asthma, dyspnea, pharyngitis, rhinitis[Ref]

Dermatologic

Common (1% to 10%): Pruritus[Ref]

Other

Common (1% to 10%): fatigue[Ref]

Hypersensitivity

Common (1% to 10%): Pruritus

Very rare (less than 0.01%): Rash[Ref]

Immunologic

Common (1% to 10%): Influenza-like symptoms[Ref]

Nervous system

Very common (10% or more): Headaches (15%)

Common (1% to 10%): Bitter taste[Ref]

References

1. Product Information. Optivar (azelastine ophthalmic). Muro Pharmaceuticals Inc. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.